Journal
CELLS
Volume 11, Issue 22, Pages -Publisher
MDPI
DOI: 10.3390/cells11223572
Keywords
gammadelta cells; immunotherapy; allogeneic; expansion; cancer; HIV; infectious diseases
Categories
Funding
- NIH [R01-AI125097, R21-AI157864]
Ask authors/readers for more resources
This manuscript reviews the major characteristics of gamma/delta T cells, the most abundant circulating subpopulation being V delta 2 T cells. It discusses their potential in cellular immunotherapy, recent advances in expansion protocols, their applications in preclinical and clinical settings for infectious diseases and malignancies, and the potential to enhance their therapeutic effects through additional modulation.
Gamma/delta (gamma delta) T cells are innate-like immune effectors that are a critical component linking innate and adaptive immune responses. They are recognized for their contribution to tumor surveillance and fight against infectious diseases. gamma delta T cells are excellent candidates for cellular immunotherapy due to their unique properties to recognize and destroy tumors or infected cells. They do not depend on the recognition of a single antigen but rather a broad-spectrum of diverse ligands through expression of various cytotoxic receptors. In this manuscript, we review major characteristics of the most abundant circulating gamma delta subpopulation, V delta 2 T cells, their immunotherapeutic potential, recent advances in expansion protocols, their preclinical and clinical applications for several infectious diseases and malignancies, and how additional modulation could enhance their therapeutic potential.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available